Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 32 clinical trials
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

This study aims to evaluate the safety, tolerability and efficacy of molnupiravir (MK-4482) compared to placebo. The primary hypothesis is that molnupiravir is superior to placebo as assessed by the percentage of participants who are hospitalized and/or die through Day 29

Emerson Clinical Research Institute ( Site 1828)
 (4.4 away) Contact site
  • 0 views
  • 13 Jun, 2021
  • +110 other locations
A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

The main purpose of this study is to measure the amount of lopinavir/ritonavir (two anti-HIV medications) in the blood. Results from this study will be compared to the levels of the drugs that have been found in other studies that showed that these medications were safe and effective.

HIV Vaccine
kaletra
ritonavir
lopinavir/ritonavir
lopinavir
Howard University Washington, DC NICHD CRS (5044)
 (5.1 away) Contact site
  • 340 views
  • 08 Nov, 2020
  • +56 other locations
PRISM Study-Pruritus Relief Through Itch Scratch Modulation

To investigate the anti-pruritic efficacy and safety of Nalbuphine ER (NAL ER) tablets in Prurigo Nodularis. Subjects will be randomized to NAL ER (or matching placebo) with the primary endpoint evaluation at Week 14. During the open label extension, subjects who received NAL ER will continue on NAL ER and …

nalbuphine
Study Site 128
 (7.0 away) Contact site
  • 661 views
  • 12 Jun, 2021
  • +85 other locations
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

This is a Phase 2/3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult and adolescent patients with active eosinophilic esophagitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of …

ak002
eosinophil count
hysterectomy
dysphagia
eosinophilia
Allakos Investigational Site
 (7.8 away) Contact site
  • 115 views
  • 22 May, 2021
  • +68 other locations
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

This study will evaluate the safety and effectiveness of the investigational drug DDP733 in treating female patients with IBS-c. A placebo control will be utilized.

abdominal pain
constipation
discomfort
Metropolitan Gastroenterology Group, PC Chevy Chase Clinical Research
 (8.1 away) Contact site
  • 5594 views
  • 07 Nov, 2020
  • +67 other locations
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

Many types of cancer are primarily treated with surgery and patient survival is directly related to the extent to which the tumor is able to be removed. It is often difficult for surgeons to distinguish tumor tissue from normal tissue or to detect tumor cells that have spread from the …

Children's National Medical Center
 (5.4 away) Contact site
  • 0 views
  • 10 May, 2021
  • +9 other locations
Tucatinib Trastuzumab Ramucirumab and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

This study is being done to see if tucatinib with trastuzumab, ramucirumab and paclitaxel works better than ramucirumab and paclitaxel to treat HER2-positive (HER2+) cancer of the gut (stomach or gastroesophageal cancer). This study will also look at what side effects happen when participants take this combination of drugs. A …

Lombardi Cancer Center / Georgetown University Medical Center
 (7.8 away) Contact site
  • 0 views
  • 09 Jun, 2021
  • +21 other locations
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity and safety profile. The Phase 3 portion is an event-driven, randomized, observer blinded, placebo-controlled design that will evaluate the efficacy and safety of the CoVLP formulation compared …

Ascension Providence Health System
 (3.1 away) Contact site
  • 0 views
  • 01 Jun, 2021
  • +73 other locations
ACTIV-2: A Study for Outpatients With COVID-19

Drug studies often look at the effect one or two drugs have on a medical condition, and involve one company. There is currently an urgent need for one study to efficiently test multiple drugs from more than one company, in people who have tested positive for COVID-19 but who do …

sore throat
fever
myalgia
pharyngitis
nausea
Whitman-Walker Health (Site 1027), 1337 R Street NW.
 (5.8 away) Contact site
  • 104 views
  • 10 Jun, 2021
  • +210 other locations
Safety Tolerability and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Phase 1 To evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral load of SARS-CoV-2 Phase 2 To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral load of SARS-CoV-2 Phase 3 Cohort …

SARS
viral shedding
oropharyngeal
covid-19
molecular diagnostic
Regeneron Study Site
 (7.0 away) Contact site
  • 4049 views
  • 01 Jun, 2021
  • +95 other locations